Ascendis Health interim results show portfolio resilience and growth

Ascendis Health (JSE:ASC) has announced its unaudited interim results for the six months ended December 31, 2024, demonstrating resilience and strategic expansion. Tangible net asset value per share rose to 105 cents, up from 94 cents in December 2023, reflecting an 11.7% increase. The growth was primarily fueled by the Medical portfolio, which saw its net asset value increase by 16.5% to R252 million since July 1, 2024. The Consumer portfolio also contributed, growing by 1% to R467 million. The company's transition to an Investment Entity, effective July 1, 2024, has changed its financial reporting basis. Consequently, earnings per share were 6.4 cents, compared to 12.7 cents in the previous period (restated to 3.4 cents). Operating profit reached R41.5 million. Ascendis is optimistic about future growth, focusing on market opportunities and strategic acquisitions. The board will adopt Net Asset Value as the Group's relevant financial measure for trading statement purposes.